Pages that link to "Q33222142"
Jump to navigation
Jump to search
The following pages link to Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis (Q33222142):
Displaying 50 items.
- Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials (Q22305464) (← links)
- Testosterone and the male skeleton: a dual mode of action (Q24594450) (← links)
- Testosterone for the aging male; current evidence and recommended practice (Q24647679) (← links)
- Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males (Q24672743) (← links)
- THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study (Q26780084) (← links)
- The treatment of late-onset hypogonadism (Q26795519) (← links)
- Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study (Q26828911) (← links)
- The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency (Q26828981) (← links)
- Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology (Q26864777) (← links)
- Testosterone and the cardiovascular system: a comprehensive review of the clinical literature (Q27000507) (← links)
- Andropause: Current concepts (Q27024886) (← links)
- Influence of androgens on circulating adiponectin in male and female rodents (Q27314775) (← links)
- Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review (Q28069320) (← links)
- Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices (Q28295533) (← links)
- Male hypogonadism (Q28300144) (← links)
- The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men (Q28540783) (← links)
- Older men exhibit reduced efficacy of and heightened potency downregulation by intravenous pulses of recombinant human LH: a study in 92 healthy men. (Q30423055) (← links)
- Effects of Testosterone and Evoked Resistance Exercise after Spinal Cord Injury (TEREX-SCI): study protocol for a randomised controlled trial (Q33552627) (← links)
- Androgen activity and markers of inflammation among men in NHANES III (Q33647847) (← links)
- Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. (Q33786842) (← links)
- Clinical significance of androgen secretion disorders in men with a malignancy. (Q33840617) (← links)
- Therapies for musculoskeletal disease: can we treat two birds with one stone? (Q33851441) (← links)
- Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes (Q33864913) (← links)
- Metabolic actions of insulin in men and women (Q33945495) (← links)
- The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2 (Q34097510) (← links)
- Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle (Q34160098) (← links)
- An update on male hypogonadism therapy (Q34207540) (← links)
- Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies (Q34267991) (← links)
- Deciphering the selective androgen receptor modulators paradigm (Q34317005) (← links)
- Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment (Q34396808) (← links)
- Testosterone and growth hormone normalization: a retrospective study of health outcomes (Q34417734) (← links)
- Safety of antiandrogen therapy for treating prostate cancer (Q34441134) (← links)
- Effects of Transdermal Testosterone on Bone and Muscle in Older Men with Low Bioavailable Testosterone Levels, Low Bone Mass, and Physical Frailty (Q34458372) (← links)
- Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels (Q34556225) (← links)
- Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones (Q34590954) (← links)
- Sarcopenia and Androgens: A Link between Pathology and Treatment (Q34730659) (← links)
- Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. (Q34758488) (← links)
- Endocrinology of the aging male (Q34777308) (← links)
- Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study (Q34804834) (← links)
- Testosterone deficiency and cardiovascular mortality (Q34927884) (← links)
- Obesity-Related Hormones and Metabolic Risk Factors: A Randomized Trial of Diet plus Either Strength or Aerobic Training versus Diet Alone in Overweight Participants (Q34948825) (← links)
- Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. (Q35032969) (← links)
- Effect of testosterone deficiency on cholesterol metabolism in pigs fed a high-fat and high-cholesterol diet (Q35170131) (← links)
- Review of health risks of low testosterone and testosterone administration (Q35335859) (← links)
- Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation (Q35459531) (← links)
- Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism (Q35624509) (← links)
- Biochemical bone turnover markers and osteoporosis in older men: where are we? (Q35636173) (← links)
- Androgens and adipose tissue in males: a complex and reciprocal interplay (Q35659922) (← links)
- Testosterone therapy increased muscle mass and lipid oxidation in aging men. (Q35678129) (← links)
- Connecting the Lines between Hypogonadism and Atherosclerosis (Q35810628) (← links)